KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Depreciation and Depletion (2016 - 2025)

Pacira BioSciences has reported Depreciation and Depletion over the past 15 years, most recently at $7.0 million for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $7.0 million for Q4 2025, up 1.45% from a year ago — trailing twelve months through Dec 2025 was $33.7 million (up 56.74% YoY), and the annual figure for FY2025 was $33.7 million, up 56.74%.
  • Depreciation and Depletion for Q4 2025 was $7.0 million at Pacira BioSciences, up from $6.9 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for PCRX hit a ceiling of $16.2 million in Q4 2022 and a floor of $2.9 million in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $5.6 million (2021), compared with a mean of $6.1 million.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 200.0% in 2022 and later plummeted 74.07% in 2023.
  • Pacira BioSciences' Depreciation and Depletion stood at $5.4 million in 2021, then skyrocketed by 200.0% to $16.2 million in 2022, then plummeted by 74.07% to $4.2 million in 2023, then surged by 64.29% to $6.9 million in 2024, then increased by 1.45% to $7.0 million in 2025.
  • The last three reported values for Depreciation and Depletion were $7.0 million (Q4 2025), $6.9 million (Q3 2025), and $13.0 million (Q2 2025) per Business Quant data.